Ai-Vidda: Hifas dam fungi and AIs alienated in a pioneer clinical trial in early Alzheimer's
Hifas da Terra is part of the Project AI-VIDDA, an initiative funded within the framework of the Feder Galicia Operational Program 2021-2027 focused on the development of advanced solutions to prevent cognitive deterioration in older people through artificial intelligence and biotechnology.
- The AI-VIDDA project has a budget of 3.6 million euros and will culminate with the participation of 500 patients, which represents the greatest clinical essay in the history of Hifas da Terra.
Hifas da Terra is positioned at the forefront of biotechnological research by being part of the Project AI-VIDDA (Artificial intelligence and biotechnology adapted to new intervention tools in older people to increase healthy life). This collaborative initiative, financed within the framework of the Feder Galicia Operational Program 2021-2027, It seeks to revolutionize the prevention and treatment of cognitive impairment in older people through integrated solutions based on artificial intelligence and biotechnology.
In addition to Hifas da Terra, in the AI-VIDDA project, Geriavi (Domusvi), Balidea Consulting & Programming, Trinidad Academia, NiuCom 180 and Inalabs Digital participate, a consortium of specialized entities in health, technology and training. With a global budget of 3.6 million euros, Of which 1.65 million are co-financed, this project is part of Galicia's intelligent specialization missions (RIS3 2021-2027). It should be noted that only two projects have been selected in this call, which underlines the competitive nature of this initiative.
Stop early Alzheimer's
The main project approach is the development of advanced tools that promote active and healthy aging. For this, large volumes of data will be managed through artificial intelligence, which will allow the creation of personalized intervention strategies. Within this initiative, Hifas da Terra will lead biotechnological research with the creation of new ingredients from medicinal fungi extracts aimed at curbing cognitive deterioration in patients with early Alzheimer's. This research will culminate in the most ambitious clinical trial carried out by the company, in collaboration with the Galicia Sur Biomedical Foundation, with the participation of 500 patients.
Medicinal fungi and artificial intelligence
The contribution of Hifas da Terra in Ai-Vidda It reflects its commitment to biotechnological innovation and the search for solutions that improve the quality of life of the elderly. This project represents a milestone in its trajectory and highlights the potential of medicinal fungi in the field of applied neuroscience.
Technological and health innovation
With Ai-Vidda, Hifas da Terra and the consortium of companies involved open a new stage in the research and development of solutions that address the challenges of aging, and consolidate Galicia as a reference in technological and health innovation.